Tissue-selective actions of estrogen analogs
Related Experiment Videos
1Department of Orthopedics, Mayo Clinic, Rochester, MN 55905, USA.
Abstract:
The biological actions of estrogen analogs have frequently confounded prevailing views regarding the mechanism of estrogen action. Agents originally intended as antifertility drugs are now used clinically to promote ovulation. The early work with antiestrogens as antifertility agents lead to the realization that triphenylethylene antiestrogens suppressed the growth of breast tumors. The subsequent ubiquitous clinical use of tamoxifen for adjuvant breast cancer therapy is a direct result of this research. Basic studies using tamoxifen and related antiestrogens revealed the previously unsuspected tissue selective actions of these compounds. This peculiar property is being taken advantage of to gain new insight into the molecular mechanisms of estrogen action. This property also forms the basis for an exciting new approach to hormone replacement therapy to prevent postmenopausal osteoporosis and cardiovascular disease. The laboratory rat played an integral and essential part in each of these developments. The success of the ovariectomized rat model in predicting the tissue selective effects of tamoxifen in women greatly increases confidence that this animal model will be useful in development of a new generation of estrogen analogs designed specifically for postmenopausal hormone replacement.
Insights
Estrogen analogs, like tamoxifen, show tissue-selective effects, impacting breast cancer therapy and hormone replacement. The ovariectomized rat model is crucial for developing new estrogen therapies.
Area of Science:
- Endocrinology
- Pharmacology
- Oncology
Background:
- Estrogen analogs have complex biological actions, challenging existing mechanisms of estrogen activity.
- Antiestrogens, initially developed as antifertility drugs, were found to inhibit breast tumor growth.
- Tamoxifen's widespread use in adjuvant breast cancer therapy stems from this discovery.
Purpose of the Study:
- To investigate the tissue-selective actions of tamoxifen and related antiestrogens.
- To explore the potential of these compounds in hormone replacement therapy for postmenopausal conditions.
- To validate the ovariectomized rat model for predicting human responses to estrogen analogs.
Main Methods:
- Utilizing tamoxifen and related triphenylethylene antiestrogens in laboratory studies.
- Employing the ovariectomized rat model to assess tissue-specific effects.
- Evaluating the efficacy of estrogen analogs in preventing osteoporosis and cardiovascular disease.
Main Results:
- Discovery of previously unsuspected tissue-selective actions of antiestrogens.
- Tamoxifen's effectiveness in suppressing breast tumor growth and its clinical application.
- Successful prediction of tamoxifen's tissue-selective effects in women using the rat model.
Conclusions:
- Tissue-selective estrogen analogs offer new insights into estrogen action mechanisms.
- These compounds provide a basis for novel hormone replacement strategies.
- The ovariectomized rat model is a reliable predictor for developing new estrogen analogs for postmenopausal therapy.